CSIMarket
 
Labcorp Holdings Inc   (NYSE: LH)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $326.8900 $-4.61 -1.391%
Day's High: $330.5400085449219 Week Perf: -1.73 %
Day's Low: $ 326.16 30 Day Perf: 3.27 %
Volume (M): 438,649 52 Wk High: $ 341.80
Volume (M$): $ 0 52 Wk Avg: $275.06
Open: $328.00 52 Wk Low: $244.52



 Market Capitalization (Millions $) 27,099
 Shares Outstanding (Millions) 83
 Employees 70,000
 Revenues (TTM) (Millions $) 14,144
 Net Income (TTM) (Millions $) 943
 Cash Flow (TTM) (Millions $) 612
 Capital Exp. (TTM) (Millions $) 430

Business Description


Company Profile: Labcorp Holdings Inc.

Overview:
Labcorp Holdings Inc. headquartered in Burlington, North Carolina, stands as the second largest independent clinical laboratory company in the United States. The company operates a national network of laboratories offering more than 4,400 clinical laboratory tests, integral to routine testing, patient diagnosis, and monitoring and treating diseases.

Services Offered:
Labcorp provides an extensive range of laboratory services which include:

- Clinical Testing: Routine laboratory tests performed on blood, urine, and other body fluids, as well as anatomical pathology testing.
- Specialized Testing: Services include oncology testing, HIV genotyping and phenotyping, diagnostic genetics, and participation in clinical research trials.
- Genomic and Advanced Testing: Leading the market in genomic testing technologies, with a strong focus on infectious diseases and cancer diagnostics.

Acquisitions:
To expand its testing capabilities, Labcorp has acquired several companies, including Dynacare Inc. and DIANON Systems, enhancing its specialty and niche businesses.

Operations:
Labcorp operates 31 primary testing facilities and over 1,200 service sites, including branches, patient service centers, and STAT laboratories. The companys in-house courier system ensures efficient specimen transport to its laboratories for testing.

Compliance and Ethics:
Labcorp is committed to maintaining the highest quality standards in laboratory services, adhering to all relevant federal, state, and local laws. The company has a stringent Code of Business Conduct and Ethics applicable to all employees and board members.

Industry Context:
The clinical laboratory testing market is vital for healthcare providers, assisting in diagnosing, evaluating, and monitoring patients health. Labcorp competes primarily with hospital-based laboratories and other independent clinical laboratories, such as Quest Diagnostics.

Client Base:
Labcorp serves a diverse clientele, including independent physicians, hospitals, HMOs, and managed care organizations, as well as governmental agencies and large employers. The company typically bills for services on a fee-for-service basis, with negotiations based on customer fee schedules.

Strategic Objectives:
Labcorp aims to grow its leadership in genomic and advanced testing technologies while broadening its testing services through continued research, development, and selective acquisitions. The company strives to develop and bring to market innovative testing technologies, enhancing patient and physician experiences.

Conclusion:
Labcorp Holdings Inc. is a prominent player in the clinical laboratory industry, poised for continued growth through innovation and strategic expansions in testing capabilities, supporting healthcare providers in delivering exceptional patient care.


   Company Address: 358 South Main Street Burlington 27215 NC
   Company Phone Number: 229-1127   Stock Exchange / Ticker: NYSE LH


Customers Net Income grew by LH's Customers Net Profit Margin grew to

56.97 %

3.79 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DGX   -2.32%    
GRAL        0.43% 
IQV        2.3% 
NOTV      0% 
RDNT   -1.21%    
XGN        2.57% 
• View Complete Report
   



Stocks on the Move

Advancements in Personalized Medicine Drive Expansion of Esoteric Testing Market Global Size to Surpass $73 Billion b...

Published Wed, Jun 26 2024 2:45 PM UTC

In recent years, significant advancements in personalized medicine and the growing demand for specialized diagnostics have propelled the expansion of the esoteric testing market. As clinical research organizations (CROs) play a crucial role in improving efficiency during the drug development process, their ranking and performance have become a key consideration for pharmaceu...

Products & Services

Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

Published Mon, Apr 15 2024 11:00 AM UTC

Labcorp Introduces Groundbreaking Blood Test for Early Detection of Neurodegenerative Diseases and Brain InjuriesLabcorp, a renowned leader in innovative diagnostic testing, has recently announced the launch of a groundbreaking blood test that can provide early indications of neurodegenerative diseases and brain injuries. This cutting-edge test utilizes a blood draw to measu...

Dividend

Labcorp's Quarterly Dividend Announcement Spurs Investor Interest, Yet Potential for Increased Returns Remains

Published Thu, Apr 11 2024 10:59 AM UTC

Labcorp Declares Quarterly Dividend and Assesses Impact on Company Shares
Labcorp, a renowned leader in innovative laboratory services, recently announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. This news has generated considerable interest in the investor community, as they assess the potential impact on the company ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 28.98
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.92
Price to Sales (Expected) -
Price to Book 3.1
PEG (TTM) 0.95

Financial Strength Current
Quick Ratio 0.4
Working Capital Ratio 1.86
Leverage Ratio (MRQ) 1.16
Total Debt to Equity 0.73
Interest Coverage (TTM) 9.24
Debt Coverage (TTM) 0.37

Per Share Current
Earnings (TTM) 11.28 $
Revenues (TTM) 170.62 $
Cash Flow (TTM) 7.38 $
Cash 11.83 $
Book Value 105.29 $
Dividend (TTM) 2.88 $

Efficiency Current
Revenue per Employee (TTM) 202,060
Net Income per Employee (TTM) 13,467
Receivable Turnover Ratio (TTM) 6.56
Inventory Turnover Ratio (TTM) 19.53
Asset Turnover Ratio (TTM) 0.76

Profitability Ratios Current
Gross Margin (MRQ) 28.66 %
Operating Margin (MRQ) 10.76 %
Net Margin (MRQ) 7.86 %
Net Cash Flow Margin (MRQ) 12.69 %
Effective Tax Rate (TTM) 18.17 %

Management Effectiveness Current
Return On Assets (TTM) 5.09 %
Return On Investment (TTM) 5.99 %
Return On Equity (TTM) 10.92 %
Dividend Yield 0.88 %
Pay out Ratio (TTM) 25.53 %



Labcorp Holdings Inc's Segments
North America    0 % of total Revenue
Europe    0 % of total Revenue
Other countries    0 % of total Revenue
UNITED STATES    82.37 % of total Revenue
Diagnostics    78.08 % of total Revenue
Diagnostics North America    0 % of total Revenue
Diagnostics Client    0 % of total Revenue
Diagnostics Client North America    0 % of total Revenue
Diagnostics Self-Pay    0 % of total Revenue
Diagnostics Self-Pay North America    0 % of total Revenue
Diagnostics Medicare and Medicaid    0 % of total Revenue
Diagnostics Medicare and Medicaid North America    0 % of total Revenue
Diagnostics Third party    0 % of total Revenue
Diagnostics Third party North America    0 % of total Revenue
Biopharma Laboratory Services    22.07 % of total Revenue
Biopharma Laboratory Services Biopharmaceutical and medical device companies    0 % of total Revenue
Biopharma Laboratory Services Biopharmaceutical and medical device companies North America    0 % of total Revenue
Biopharma Laboratory Services Biopharmaceutical and medical device companies Europe    0 % of total Revenue
Biopharma Laboratory Services Biopharmaceutical and medical device companies Other countries    0 % of total Revenue
InterEliminations    0.14 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.